Rory Mitchell, Ph.D. - Publications

Affiliations: 
Centre for Integrative Physiology University of Edinburgh, Edinburgh, Scotland, United Kingdom 
Area:
GPCRs, Signalling pathways
Website:
http://www.ed.ac.uk/schools-departments/integrative-physiology/staff-profiles/rory-mitchell

94 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Licht-Mayer S, Campbell GR, Canizares M, Mehta AR, Gane AB, McGill K, Ghosh A, Fullerton A, Menezes N, Dean J, Dunham J, Al-Azki S, Pryce G, Zandee S, Zhao C, ... ... Mitchell R, et al. Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis. Acta Neuropathologica. PMID 32572598 DOI: 10.1007/S00401-020-02179-X  0.568
2020 Mitchell R, Mikolajczak M, Kersten C, Fleetwood-Walker S. ErbB1-dependent signalling and vesicular trafficking in primary afferent nociceptors associated with hypersensitivity in neuropathic pain. Neurobiology of Disease. 104961. PMID 32531343 DOI: 10.1016/J.Nbd.2020.104961  0.681
2020 Sun L, Fleetwood-Walker S, Mitchell R, Joosten EA, Cheung CW. Prolonged analgesia by spinal cord stimulation following a spinal injury associated with activation of adult neural progenitors. Pain Practice : the Official Journal of World Institute of Pain. PMID 32474998 DOI: 10.1111/Papr.12921  0.608
2019 Kersten C, Cameron MG, Bailey AG, Fallon MT, Laird BJ, Paterson V, Mitchell R, Fleetwood-Walker SM, Daly F, Mjåland S. Relief of Neuropathic Pain Through Epidermal Growth Factor Receptor Inhibition: A Randomized Proof-of-Concept Trial. Pain Medicine (Malden, Mass.). PMID 31106835 DOI: 10.1093/Pm/Pnz101  0.648
2019 Mitchell R, Campbell G, Mikolajczak M, McGill K, Mahad D, Fleetwood-Walker SM. A Targeted Mutation Disrupting Mitochondrial Complex IV Function in Primary Afferent Neurons Leads to Pain Hypersensitivity Through P2Y Receptor Activation. Molecular Neurobiology. PMID 30689196 DOI: 10.1007/S12035-018-1455-4  0.682
2017 Greaves E, Horne AW, Jerina H, Mikolajczak M, Hilferty L, Mitchell R, Fleetwood-Walker SM, Saunders PT. EP2 receptor antagonism reduces peripheral and central hyperalgesia in a preclinical mouse model of endometriosis. Scientific Reports. 7: 44169. PMID 28281561 DOI: 10.1038/Srep44169  0.693
2017 Sun L, Tai L, Qiu Q, Mitchell R, Fleetwood-Walker S, Joosten EA, Cheung CW. Endocannabinoid activation of CB1 receptors contributes to long-lasting reversal of neuropathic pain by repetitive spinal cord stimulation. European Journal of Pain (London, England). PMID 28107590 DOI: 10.1002/Ejp.983  0.667
2015 Fallon MT, Storey DJ, Krishan A, Weir CJ, Mitchell R, Fleetwood-Walker SM, Scott AC, Colvin LA. Cancer treatment-related neuropathic pain: proof of concept study with menthol-a TRPM8 agonist. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 25680765 DOI: 10.1007/S00520-015-2642-8  0.638
2014 Vinuela-Fernandez I, Sun L, Jerina H, Curtis J, Allchorne A, Gooding H, Rosie R, Holland P, Tas B, Mitchell R, Fleetwood-Walker S. The TRPM8 channel forms a complex with the 5-HT(1B) receptor and phospholipase D that amplifies its reversal of pain hypersensitivity. Neuropharmacology. 79: 136-51. PMID 24269608 DOI: 10.1016/J.Neuropharm.2013.11.006  0.672
2014 Sande TA, Scott AC, Laird BJ, Wan HI, Fleetwood-Walker SM, Kaasa S, Klepstad P, Mitchell R, Murray GD, Colvin LA, Fallon MT. The characteristics of physical activity and gait in patients receiving radiotherapy in cancer induced bone pain. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 111: 18-24. PMID 24231246 DOI: 10.1016/J.Radonc.2013.10.023  0.621
2013 Sun L, Gooding HL, Brunton PJ, Russell JA, Mitchell R, Fleetwood-Walker S. Phospholipase D-mediated hypersensitivity at central synapses is associated with abnormal behaviours and pain sensitivity in rats exposed to prenatal stress. The International Journal of Biochemistry & Cell Biology. 45: 2706-12. PMID 23932932 DOI: 10.1016/J.Biocel.2013.07.017  0.681
2013 Barclay Z, Dickson L, Robertson D, Johnson M, Holland P, Rosie R, Sun L, Jerina H, Lutz E, Fleetwood-Walker S, Mitchell R. Attenuated PLD1 association and signalling at the H452Y polymorphic form of the 5-HT(2A) receptor. Cellular Signalling. 25: 814-21. PMID 23314176 DOI: 10.1016/J.Cellsig.2013.01.004  0.769
2013 Gauff F, Jerina H, Jones E, Mitchell R, Fleetwood-Walker S, Licka T. Pain-associated changes in the dorsal root ganglia of laminitic horses Journal of Equine Veterinary Science. 33: 871. DOI: 10.1016/J.Jevs.2013.08.054  0.629
2012 Allchorne AJ, Gooding HL, Mitchell R, Fleetwood-Walker SM. A novel model of combined neuropathic and inflammatory pain displaying long-lasting allodynia and spontaneous pain-like behaviour. Neuroscience Research. 74: 230-8. PMID 23131427 DOI: 10.1016/J.Neures.2012.10.006  0.641
2012 Fleetwood-Walker S, Sun L, Jerina H, Mitchell R. Assessment of animal pain and mechanism-based strategies for its reversal. Veterinary Journal (London, England : 1997). 193: 305-6. PMID 22884986 DOI: 10.1016/J.Tvjl.2012.07.017  0.626
2011 Barclay Z, Dickson L, Robertson DN, Johnson MS, Holland PJ, Rosie R, Sun L, Fleetwood-Walker S, Lutz EM, Mitchell R. 5-HT2A receptor signalling through phospholipase D1 associated with its C-terminal tail. The Biochemical Journal. 436: 651-60. PMID 21410433 DOI: 10.1042/Bj20101844  0.768
2010 Storey DJ, Colvin LA, Mackean MJ, Mitchell R, Fleetwood-Walker SM, Fallon MT. Reversal of dose-limiting carboplatin-induced peripheral neuropathy with TRPM8 activator, menthol, enables further effective chemotherapy delivery. Journal of Pain and Symptom Management. 39: e2-4. PMID 20538177 DOI: 10.1016/J.Jpainsymman.2010.02.004  0.583
2010 Arbuckle MI, Komiyama NH, Delaney A, Coba M, Garry EM, Rosie R, Allchorne AJ, Forsyth LH, Bence M, Carlisle HJ, O'Dell TJ, Mitchell R, Fleetwood-Walker SM, Grant SG. The SH3 domain of postsynaptic density 95 mediates inflammatory pain through phosphatidylinositol-3-kinase recruitment. Embo Reports. 11: 473-8. PMID 20467438 DOI: 10.1038/Embor.2010.63  0.638
2010 Scott AC, Laird BJ, Wan HI, Fleetwood-Walker SM, Mitchell R, Murray GD, Colvin LA, Fallon MT. Use of thermal sensation as a biomarker of response to palliative radiotherapy for cancer-induced bone pain. Journal of Clinical Oncology. 28: 9068-9068. DOI: 10.1200/Jco.2010.28.15_Suppl.9068  0.623
2010 Currie G, Delaney A, Robertson D, Allchorne A, Anderson H, Garry EM, Fallon M, Colvin LA, Mitchell R, Fleetwood-Walker S. Central sensitization in a model of cancer-induced bone pain is dependent on N-methyl-D-aspartate receptors containing the NR2A subunit Bja: British Journal of Anaesthesia. 104: 517-518. DOI: 10.1093/Bja/Aep362  0.655
2009 Delaney A, Colvin LA, Fallon MT, Dalziel RG, Mitchell R, Fleetwood-Walker SM. Postherpetic neuralgia: from preclinical models to the clinic. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 6: 630-7. PMID 19789068 DOI: 10.1016/J.Nurt.2009.07.005  0.586
2008 Colvin LA, Johnson PR, Mitchell R, Fleetwood-Walker SM, Fallon M. From bench to bedside: a case of rapid reversal of bortezomib-induced neuropathic pain by the TRPM8 activator, menthol. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4519-20. PMID 18802169 DOI: 10.1200/Jco.2008.18.5017  0.641
2007 Fleetwood-Walker SM, Proudfoot CW, Garry EM, Allchorne A, Vinuela-Fernandez I, Mitchell R. Cold comfort pharm. Trends in Pharmacological Sciences. 28: 621-8. PMID 17996956 DOI: 10.1016/J.Tips.2007.10.007  0.651
2007 Fleetwood-Walker SM, Proudfoot CJ, Garry EM, Cottrell DF, Rosie R, Anderson H, Delaney A, Robertson DC, Mitchell R. 72 Laboratory Models Of Neuropathic Pain And Their Application In Developing New Analgesics European Journal of Pain. 11: 29. DOI: 10.1016/J.Ejpain.2007.03.086  0.327
2006 Proudfoot CJ, Garry EM, Cottrell DF, Rosie R, Anderson H, Robertson DC, Fleetwood-Walker SM, Mitchell R. Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain. Current Biology : Cb. 16: 1591-605. PMID 16920620 DOI: 10.1016/J.Cub.2006.07.061  0.694
2006 Johnson MS, Robertson DN, Holland PJ, Lutz EM, Mitchell R. Role of the conserved NPxxY motif of the 5-HT2A receptor in determining selective interaction with isoforms of ADP-ribosylation factor (ARF). Cellular Signalling. 18: 1793-800. PMID 16545942 DOI: 10.1016/J.Cellsig.2006.02.002  0.671
2006 Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP. Molecular and Cellular Neurosciences. 31: 193-209. PMID 16226889 DOI: 10.1016/J.Mcn.2005.09.008  0.433
2005 Garry EM, Delaney A, Blackburn-Munro G, Dickinson T, Moss A, Nakalembe I, Robertson DC, Rosie R, Robberecht P, Mitchell R, Fleetwood-Walker SM. Activation of p38 and p42/44 MAP kinase in neuropathic pain: involvement of VPAC2 and NK2 receptors and mediation by spinal glia. Molecular and Cellular Neurosciences. 30: 523-37. PMID 16202621 DOI: 10.1016/J.Mcn.2005.08.016  0.67
2005 Wilson JA, Garry EM, Anderson HA, Rosie R, Colvin LA, Mitchell R, Fleetwood-Walker SM. NMDA receptor antagonist treatment at the time of nerve injury prevents injury-induced changes in spinal NR1 and NR2B subunit expression and increases the sensitivity of residual pain behaviours to subsequently administered NMDA receptor antagonists. Pain. 117: 421-32. PMID 16150544 DOI: 10.1016/J.Pain.2005.07.005  0.659
2003 Robertson DN, Johnson MS, Moggach LO, Holland PJ, Lutz EM, Mitchell R. Selective interaction of ARF1 with the carboxy-terminal tail domain of the 5-HT2A receptor. Molecular Pharmacology. 64: 1239-50. PMID 14573774 DOI: 10.1124/Mol.64.5.1239  0.675
2003 Garry EM, Moss A, Rosie R, Delaney A, Mitchell R, Fleetwood-Walker SM. Specific involvement in neuropathic pain of AMPA receptors and adapter proteins for the GluR2 subunit. Molecular and Cellular Neurosciences. 24: 10-22. PMID 14550765 DOI: 10.1016/S1044-7431(03)00134-9  0.695
2003 Mitchell R, Robertson DN, Holland PJ, Collins D, Lutz EM, Johnson MS. ADP-ribosylation factor-dependent phospholipase D activation by the M3 muscarinic receptor. The Journal of Biological Chemistry. 278: 33818-30. PMID 12799371 DOI: 10.1074/Jbc.M305825200  0.688
2003 Johnson MS, Lutz EM, Firbank S, Holland PJ, Mitchell R. Functional interactions between native Gs-coupled 5-HT receptors in HEK-293 cells and the heterologously expressed serotonin transporter. Cellular Signalling. 15: 803-11. PMID 12781873 DOI: 10.1016/S0898-6568(03)00013-5  0.311
2003 Garry EM, Moss A, Delaney A, O'Neill F, Blakemore J, Bowen J, Husi H, Mitchell R, Grant SG, Fleetwood-Walker SM. Neuropathic sensitization of behavioral reflexes and spinal NMDA receptor/CaM kinase II interactions are disrupted in PSD-95 mutant mice. Current Biology : Cb. 13: 321-8. PMID 12593798 DOI: 10.1016/S0960-9822(03)00084-8  0.682
2002 Ronaldson E, Robertson DN, Johnson MS, Holland PJ, Mitchell R, Lutz EM. Specific interaction between the hop1 intracellular loop 3 domain of the human PAC(1) receptor and ARF. Regulatory Peptides. 109: 193-8. PMID 12409233 DOI: 10.1016/S0167-0115(02)00204-5  0.684
2002 McCulloch DA, MacKenzie CJ, Johnson MS, Robertson DN, Holland PJ, Ronaldson E, Lutz EM, Mitchell R. Additional signals from VPAC/PAC family receptors. Biochemical Society Transactions. 30: 441-6. PMID 12196111 DOI: 10.1042/Bst0300441  0.68
2002 Moss A, Blackburn-Munro G, Garry EM, Blakemore JA, Dickinson T, Rosie R, Mitchell R, Fleetwood-Walker SM. A role of the ubiquitin-proteasome system in neuropathic pain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 1363-72. PMID 11850463  0.634
2002 Ronaldson E, Robertson DN, Johnson MS, Holland PJ, Mitchell R, Lutz EM. Specific interaction between ARF6 and the Hop-1 intracellular loop 3 domain of the human PAC 1 receptor Biochemical Society Transactions. 30: A87-A87. DOI: 10.1042/Bst030A087A  0.639
2001 MacKenzie CJ, Lutz EM, Johnson MS, Robertson DN, Holland PJ, Mitchell R. Mechanisms of phospholipase C activation by the vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide type 2 receptor. Endocrinology. 142: 1209-17. PMID 11181537 DOI: 10.1210/Endo.142.3.8013  0.664
2001 Robertson DN, Johnson MS, Lutz EM, Holland PJ, Mitchell R. A role for receptor internalisation in M3 muscarinic receptor association with ARF and activation of phospholipase D Biochemical Society Transactions. 29: A85-A85. DOI: 10.1042/Bst029A085B  0.675
2001 Johnson MS, Lutz EM, Holland PJ, Mitchell R. New epitope-tagged constructs of the human 5-HT2A receptor Biochemical Society Transactions. 29. DOI: 10.1042/Bst029A081  0.363
2001 Robertson DN, Beggs JK, Collins DM, Johnson MS, Holland PJ, Lutz EM, Dubois T, Aitken A, Mitchell R. 14-3-3 ζ docking to the M3 muscarinic receptor Biochemical Society Transactions. 29: A80-A80. DOI: 10.1042/Bst029A080C  0.647
2001 Robertson DN, Johnson MS, Holland PJ, Mitchell R. Association of small G protein ARF1 with the third intracellular loop of the M3 muscarinic receptor Biochemical Society Transactions. 29: A75-A75. DOI: 10.1042/Bst029A075B  0.645
2000 Johnson MS, Lutz EM, MacKenzie CJ, Wolbers WB, Robertson DN, Holland PJ, Mitchell R. Gonadotropin-Releasing Hormone Receptor Activation of Extracellular Signal-Regulated Kinase and Tyrosine Kinases in Transfected GH3 Cells and in αT3-1 Cells. Endocrinology. 141: 3087-3097. PMID 28201222 DOI: 10.1210/endo.141.9.7657  0.611
2000 McCulloch DA, Lutz EM, Johnson MS, MacKenzie CJ, Mitchell R. Differential activation of phospholipase D by VPAC and PAC1 receptors Annals of the New York Academy of Sciences. 921: 175-185. PMID 11193821 DOI: 10.1111/J.1749-6632.2000.Tb06964.X  0.448
2000 Johnson MS, Lutz EM, MacKenzie CJ, Wolbers WB, Robertson DN, Holland PJ, Mitchell R. Gonadotropin-releasing hormone receptor activation of extracellular signal-regulated kinase and tyrosine kinases in transfected GH3 cells and in alphaT3-1 cells. Endocrinology. 141: 3087-97. PMID 10965878 DOI: 10.1210/Endo.141.9.7657  0.635
1999 MacEwan DJ, Johnson MS, Mitchell R. Protein kinase C isoforms in pituitary cells displaying differential sensitivity to phorbol ester Molecular and Cellular Biochemistry. 202: 85-90. PMID 10705998 DOI: 10.1023/A:1007090718274  0.303
1999 Lutz EM, MacKenzie CJ, Johnson M, West K, Morrow JA, Harmar AJ, Mitchell R. Domains determining agonist selectivity in chimaeric VIP2 (VPAC2)/PACAP (PAC1) receptors. British Journal of Pharmacology. 128: 934-40. PMID 10556928 DOI: 10.1038/Sj.Bjp.0702872  0.438
1999 Dickinson T, Mitchell R, Robberecht P, Fleetwood-Walker SM. The role of VIP/PACAP receptor subtypes in spinal somatosensory processing in rats with an experimental peripheral mononeuropathy. Neuropharmacology. 38: 167-80. PMID 10193908 DOI: 10.1016/S0028-3908(98)00171-3  0.717
1999 Lutz EM, MacKenzie CJ, Johnson MS, West K, Harmar AJ, Mitchell R. Juxtaposition of VIP2 (VPAC2) receptor extracellular domains is necessary for VIP but not PACAP activation of the receptor Biochemical Society Transactions. 27. DOI: 10.1042/Bst027A118B  0.427
1999 McCulloch DA, Lutz EM, Johnson MS, MacKenzie CJ, Mitchell R. The role of receptor intracellular loop 3 in the differential activation of phospholipase D by VPAC and PAC1 receptors Biochemical Society Transactions. 27. DOI: 10.1042/Bst027A118A  0.431
1999 Johnson MS, Lutz EM, Firbank S, MacKenzie CJ, Mitchell R. Expression of the human serotonin transporter in HEK 293 cells; interaction with an endogenous 5-HT7 receptor Biochemical Society Transactions. 27. DOI: 10.1042/Bst027A118  0.313
1999 Robertson D, Johnson M, McCulloch D, Lutz E, Holland P, Mitchell R. Divergent pathways of phospholipase D activation in the human 5-HT2A receptor and its N376D mutant Biochemical Society Transactions. 27: A117-A117. DOI: 10.1042/Bst027A117C  0.659
1998 Mitchell R, McCulloch D, Lutz E, Johnson M, MacKenzie C, Fennell M, Fink G, Zhou W, Sealfon SC. Rhodopsin-family receptors associate with small G proteins to activate phospholipase D Nature. 392: 411-414. PMID 9537328 DOI: 10.1038/32937  0.441
1996 MacKenzie CJ, Lutz EM, McCulloch DA, Mitchell R, Harmar AJ. Phospholipase C activation by VIP1 and VIP2 receptors expressed in COS 7 cells involves a pertussis toxin-sensitive mechanism. Annals of the New York Academy of Sciences. 805: 579-84. PMID 8993443 DOI: 10.1111/J.1749-6632.1996.Tb17523.X  0.367
1996 Lutz EM, MacKenzie CJ, Morrow J, Mitchell R, Bennie J, Carroll S, Clark E, Harmar AJ. Chimaeric VIP2/PACAP receptors reveal that agonist pharmacology but not signal transduction is determined by extracellular domain 1. Annals of the New York Academy of Sciences. 805: 574-8. PMID 8993442 DOI: 10.1111/J.1749-6632.1996.Tb17522.X  0.398
1996 Johnson MS, Simpson J, Mitchell R. Effect of phorbol 12,13-dibutyrate on ligand binding, enzyme activity and translocation of protein kinase C isoforms in the αT3-1 gonadotrope-derived cell line Molecular and Cellular Biochemistry. 165: 65-75. PMID 8974082 DOI: 10.1007/Bf00229746  0.3
1995 Young MR, Fleetwood-Walker SM, Mitchell R, Dickinson T. The involvement of metabotropic glutamate receptors and their intracellular signalling pathways in sustained nociceptive transmission in rat dorsal horn neurons. Neuropharmacology. 34: 1033-41. PMID 8532152 DOI: 10.1016/0028-3908(95)00071-D  0.657
1995 Johnson MS, Wolbers WB, Noble J, Fennell M, Mitchell R. Effect of tyrosine kinase inhibitors on luteinizing hormone-releasing hormone (LHRH)-induced gonadotropin release from the anterior pituitary Molecular and Cellular Endocrinology. 109: 69-75. PMID 7789617 DOI: 10.1016/0303-7207(95)03484-O  0.319
1995 Lutz EM, Mendelson S, West K, Mitchell R, Harmar AJ. Molecular characterisation of novel receptors for PACAP and VIP. Biochemical Society Transactions. 23: 83S. PMID 7758803 DOI: 10.1042/Bst023083S  0.399
1995 Sim P, Mitchell R. Activation of MAP kinase by the LHRH receptor through a PKC-dependent pertussis toxin-sensitive mechanism Biochemical Society Transactions. 23: 144S. PMID 7758711 DOI: 10.1042/Bst023144S  0.376
1995 Mitchell R, McConnell SK, Sim P. Phospholipase C-dependent activation of tyrosine kinases by LHRH in alpha T3-1 cells, and its role in LHRH priming of inositol phosphate production. Biochemical Society Transactions. 23: 143S. PMID 7758710 DOI: 10.1042/Bst023143S  0.338
1995 Mitchell R, Wolbers WB, Sim P, Fennell M. The regulation of phospholipase C (PLC) and phospholipase D (PLD) by G protein receptor-activated tyrosine kinases in αT3-1 cells Biochemical Society Transactions. 23: 208S. PMID 7672229 DOI: 10.1042/Bst023208S  0.389
1995 Wolbers B, Simpson J, Mitchell R. LHRH-induced tyrosine phosphorylation and MAP kinase activation in αT3-1 cells Biochemical Society Transactions. 23: 145S. PMID 7538944 DOI: 10.1042/Bst023145S  0.368
1995 Sim PJ, Bart Wolbers W, Mitchell R. Activation of MAP kinase by the LHRH receptor through a dual mechanism involving protein kinase C and a pertussis toxin-sensitive G protein Molecular and Cellular Endocrinology. 112: 257-263. PMID 7489830 DOI: 10.1016/0303-7207(95)03616-F  0.407
1994 Young MR, Fleetwood-Walker SM, Mitchell R, Munro FE. Evidence for a role of metabotropic glutamate receptors in sustained nociceptive inputs to rat dorsal horn neurons. Neuropharmacology. 33: 141-4. PMID 8183438 DOI: 10.1016/0028-3908(94)90109-0  0.672
1994 Munro FE, Fleetwood-Walker SM, Mitchell R. Evidence for a role of protein kinase C in the sustained activation of rat dorsal horn neurons evoked by cutaneous mustard oil application. Neuroscience Letters. 170: 199-202. PMID 8058187 DOI: 10.1016/0304-3940(94)90318-2  0.626
1993 Ison AJ, MacEwan DJ, Johnson MS, Clegg RA, Connor K, Mitchell R. Evidence for a distinct H7-resistant form of protein kinase C in rat anterior pituitary gland Febs Letters. 329: 199-204. PMID 8354395 DOI: 10.1016/0014-5793(93)80221-F  0.302
1993 Fleetwood-Walker SM, Parker RM, Munro FE, Young MR, Hope PJ, Mitchell R. Evidence for a role of tachykinin NK2 receptors in mediating brief nociceptive inputs to rat dorsal horn (laminae III-V) neurons. European Journal of Pharmacology. 242: 173-81. PMID 8253113 DOI: 10.1016/0014-2999(93)90077-U  0.674
1993 Thomson FJ, Johnson MS, Mitchell R, Wolbers WB, Ison AJ, MacEwan DJ. The differential effects of protein kinase C activators and inhibitors on rat anterior pituitary hormone release Molecular and Cellular Endocrinology. 94: 223-234. PMID 8224525 DOI: 10.1016/0303-7207(93)90171-F  0.3
1990 Hope PJ, Fleetwood-Walker SM, Mitchell R. Distinct antinociceptive actions mediated by different opioid receptors in the region of lamina I and laminae III-V of the dorsal horn of the rat. British Journal of Pharmacology. 101: 477-83. PMID 2175238 DOI: 10.1111/J.1476-5381.1990.Tb12733.X  0.67
1990 Fleetwood-Walker SM, Mitchell R, Hope PJ, El-Yassir N, Molony V, Bladon CM. The involvement of neurokinin receptor subtypes in somatosensory processing in the superficial dorsal horn of the cat. Brain Research. 519: 169-82. PMID 1697775 DOI: 10.1016/0006-8993(90)90075-M  0.661
1989 Ogier SA, Mitchell R, Bladon CM. Novel ligands for the affinity labelling of luteinizing hormone releasing hormone receptors Biochemical Journal. 258: 881-888. PMID 2543363 DOI: 10.1042/Bj2580881  0.329
1989 Johnson MS, Mitchell R. Phorbol ester-induced release of luteinizing hormone and growth hormone from rat anterior pituitary are differentially inhibited by the protein kinase C antagonists H7 and staurosporine Biochemical Society Transactions. 17: 751-752. DOI: 10.1042/Bst0170751  0.33
1989 Mitchell R, Johnson M, Dougan L. Differential effects of protein kinase C activators on receptor-operated 45 Ca 2+ influx in pituitary tissue Biochemical Society Transactions. 17: 750-751. DOI: 10.1042/Bst0170750  0.351
1989 Bladon CM, Mitchell R, Ogier S. Preparation and use of biotinylated ligands for LHRH receptor purification Tetrahedron Letters. 30: 1401-1404. DOI: 10.1016/S0040-4039(00)99476-0  0.347
1988 el-Yassir N, Fleetwood-Walker SM, Mitchell R. Heterogeneous effects of serotonin in the dorsal horn of rat: the involvement of 5-HT1 receptor subtypes. Brain Research. 456: 147-58. PMID 2970278 DOI: 10.1016/0006-8993(88)90356-3  0.634
1988 Fleetwood-Walker SM, Hope PJ, Mitchell R, el-Yassir N, Molony V. The influence of opioid receptor subtypes on the processing of nociceptive inputs in the spinal dorsal horn of the cat. Brain Research. 451: 213-26. PMID 2855212 DOI: 10.1016/0006-8993(88)90766-4  0.656
1988 Fleetwood-Walker SM, Hope PJ, Mitchell R. Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones. The Journal of Physiology. 399: 335-48. PMID 2841456 DOI: 10.1113/Jphysiol.1988.Sp017084  0.654
1988 Mitchell R, Johnson M, Ogier S. Regulation of receptor-operated Ca 2+ influx by protein kinase C Biochemical Society Transactions. 16: 597-598. DOI: 10.1042/Bst0160597  0.345
1988 Fleetwood-Walker SM, Hope PJ, Mitchell R, El-Yassir N. Effects of agonists selective for NK-1, NK-2 and NK-3 receptors on somatosensory transmission in superficial dorsal horn Regulatory Peptides. 22: 67. DOI: 10.1016/0167-0115(88)90287-X  0.349
1987 Ogier S-, Mitchell R, Fink G. Solubilization of a large molecular weight form of the rat LHRH receptor. Journal of Endocrinology. 115: 151-159. PMID 2822831 DOI: 10.1677/Joe.0.1150151  0.377
1987 Ogier S, Mitchell R, Fink G. High yield solubilization of undenatured luteinizing hormone-releasing hormone receptors from rat anterior pituitary Biochemical Society Transactions. 15: 138-138. DOI: 10.1042/Bst0150138  0.308
1986 Anderson R, Mitchell R. Biphasic effect of GABAA receptor agonists on prolactin secretion: Evidence for two types of GABAA receptor complex on lactotrophes European Journal of Pharmacology. 124: 1-9. PMID 3013656 DOI: 10.1016/0014-2999(86)90118-4  0.344
1985 Anderson RA, Mitchell R. Evidence for GABAB autoreceptors in median eminence European Journal of Pharmacology. 118: 355-358. PMID 3002813 DOI: 10.1016/0014-2999(85)90148-7  0.341
1985 Fleetwood-Walker SM, Mitchell R, Hope PJ, Molony V, Iggo A. An alpha 2 receptor mediates the selective inhibition by noradrenaline of nociceptive responses of identified dorsal horn neurones. Brain Research. 334: 243-54. PMID 2986783 DOI: 10.1016/0006-8993(85)90216-1  0.641
1985 Mitchell R, Anderson R. Antagonism by strychnine differentiates two subtypes of GABAA-receptor complex Biochemical Society Transactions. 13: 1216-1217. DOI: 10.1042/Bst0131216  0.378
1985 Mitchell R, Riley S. Characterization of receptors for 5-hydroxytryptamine in spinal cord Biochemical Society Transactions. 13: 955-955. DOI: 10.1042/Bst0130955  0.36
1985 Mitchell R, Anderson R. Does an anion channel mediate the action of kappa opioid receptors Regulatory Peptides. 4: 191. DOI: 10.1016/0167-0115(85)90247-2  0.342
1984 Fleetwood-Walker SM, Mitchell R, Hope PJ, Molony V, Iggo A. An α2 receptor mediates the selective antinociceptive effect of noradrenaline on identified dorsal horn neurones Pain. 18: S278. DOI: 10.1016/0304-3959(84)90550-5  0.384
1981 Mitchell R, Fleetwood-Walker S. Substance P, but not TRH, modulates the 5-HT autoreceptor in ventral lumbar spinal cord. European Journal of Pharmacology. 76: 119-20. PMID 6172281 DOI: 10.1016/0014-2999(81)90020-0  0.595
1980 Mitchell R, Martin I. Ethyl β-carboline-3-carboxylate antagonises the effect of diazepam on a functional gaba receptor European Journal of Pharmacology. 68: 513-514. PMID 6258938 DOI: 10.1016/0014-2999(80)90430-6  0.306
1980 Mitchell R. A novel GABA receptor modulates stimulus-induced glutamate release from cortico-striatal terminals European Journal of Pharmacology. 67: 119-122. PMID 6252021 DOI: 10.1016/0014-2999(80)90018-7  0.339
1980 Mitchell R. Benzodiazepines modify the agonist responses at a presynaptic GABA receptor European Journal of Pharmacology. 68: 369-372. PMID 6110546 DOI: 10.1016/0014-2999(80)90535-X  0.338
Show low-probability matches.